Seven Eight Capital, LP Tilray Brands, Inc. Transaction History

Seven Eight Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.11 - $17.84 $542,656 - $871,376	-48,844 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$13.68 - $22.34 $567,323 - $926,462	-41,471 Reduced 45.92%	48,844 $883,000
Q4 2020 Feb 09, 2021	BUY	$4.82 - $10.1 $435,318 - $912,181	90,315 New	90,315 $746,000
Q1 2020 May 14, 2020	SELL	$2.47 - $21.36 $265,339 - $2.29 Million	-107,425 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$15.72 - $24.88 $402,306 - $636,728	-25,592 Reduced 19.24%	107,425 $1.84 Million
Q3 2019 Nov 14, 2019	BUY	$24.74 - $49.3 $3.29 Million - $6.56 Million	133,017 New	133,017 $3.29 Million

406

99.8M

8.6M

8.9M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $832M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.